Stem Cell Transplant for Bone Marrow Failure Syndromes
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The researchers hypothesize that it will be possible to perform unrelated bone marrow or cord
blood transplants in a safer manner by using less intensive therapy yet still achieve an
acceptable level of donor cell engraftment for non-malignant congenital bone marrow failure
disorders.